<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03975348</url>
  </required_header>
  <id_info>
    <org_study_id>123/2018</org_study_id>
    <nct_id>NCT03975348</nct_id>
  </id_info>
  <brief_title>Ventilation Distribution After Bariatric Surgery</brief_title>
  <official_title>Evaluation of Ventilation Distribution After Bariatric Surgery - High Flow Nasal Cannulas Versus Continuous Positive Airway Pressure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Trieste</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Trieste</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obese patients have an increased risk of developing post-operative respiratory complications
      due to their comorbidities. They have a restrictive ventilatory defect with reduction of lung
      volumes and expiratory flow limitation, higher airway resistance and collapsibility of the
      upper respiratory tract. These abnormalities are worsened by general anesthesia and opioid
      administration. It has been proved that oxygen therapy with HFNC (high flow nasal cannula)
      increases lung volumes through a continuous positive airway pressure (CPAP)-effect. This also
      improves gas exchange and decreases anatomical dead space. At the present time, CPAP
      represents the gold standard for the prevention of postoperative pulmonary complications. The
      purpose of this study is to evaluate lung ventilation, gas exchange and comfort with HFNC
      compared with CPAP during the post-operative period in patients who undergo laparoscopic
      bariatric surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Immediately after bariatric surgery, patients will follow a pre-determined schedule of oxygen
      therapy with conventional facemask (from the beginning to minute 10), HFNC (with a flow of 40
      L/min from minute 11 to 20, 60 L/min from minute 21to 30, 80 L/min from minute 31 to 40, 100
      L/min from minute 41 to 50, 80 L/min from minute 51 to 60, 60 L/min from minute 61 to 70, 40
      L/min from minute 71 to 80), conventional facemask again (washout, from minute 81 to 90) and
      CPAP (10 cmH2O, from minute 91 to 100). Lung ventilation will be evaluated with electrical
      impedance tomography (EIT), which measures thoracic impedance variations related to changes
      in lung aeration. At the end of each 10 minutes-period the following data will be collected:
      electrical impedance tomography data (to calculate the global inhomogeneity index, Δ
      end-expiratory lung impedance and tidal impedance variation), hemodynamic parameters,
      respiratory rate, SpO2, pain (numerical rating scale), level of sedation (Ramsey score) and
      patient comfort (modified Borg scale). An arterial blood gas will be collected at the end of
      the following steps: baseline facemask, HFNC 40 and 100 L/min, washout facemask and CPAP.
      Data about anesthetic/analgesic drugs and ventilation parameters will also be collected.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 15, 2019</start_date>
  <completion_date type="Anticipated">August 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of global inhomogeneity index</measure>
    <time_frame>The data needed to calculate the index will be collected at minute 10, 20, 30, 40, 50, 60, 70, 80, 90 and 100 (i.e. at the end of every step of oxygen therapy). The values obtained will then all be compared each other.</time_frame>
    <description>This parameter, calculated from data collected with EIT, evaluates lung ventilation distribution. To calculate this index, the median value of regional impedance changes from ventilated regions within the tidal image has to be computed, then the sum of differences between the median and every pixel value needs to be calculated, and the result must be normalised by the sum of impedance values within the lung area. The minimum value of the index is 0 and corresponds to homogeneous ventilation, whereas the maximum value is 1 and corresponds to inhomogeneous ventilation (in this context likely due to atelectasis).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of Δ end expiratory lung impedance (ΔEELI)</measure>
    <time_frame>The data will be collected at minute 10, 20, 30, 40, 50, 60, 70, 80, 90 and 100 (i.e. at the end of every step of oxygen therapy). The values obtained will then all be compared each other.</time_frame>
    <description>The parameter, measured with EIT, expresses deviations of the regional end-expiratory lung impedance in relation to the global tidal impedance variation. ΔEELI closely correlates with changes of end-expiratory lung volume of the EIT sensitivity region.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of tidal impedance variation</measure>
    <time_frame>The data will be collected at minute 10, 20, 30, 40, 50, 60, 70, 80, 90 and 100 (i.e. at the end of every step of oxygen therapy). The values obtained will then all be compared each other.</time_frame>
    <description>This parameter, measured with EIT, corresponds to the difference between end-expiratory and end-inspiratory lung impedance and is related to tidal volume. It will be expressed in units, where one unit corresponds to the tidal impedance variation of the patient breathing with baseline conventional facemask.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of oxygenation</measure>
    <time_frame>The blood gas analysis will be performed at minute 10, 20, 50, 90 and 100. The values will then all be compared each other.</time_frame>
    <description>Oxygen arterial partial pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of carbon dioxide</measure>
    <time_frame>The blood gas analysis will be performed at minute 10, 20, 50, 90 and 100. The values will then all be compared each other.</time_frame>
    <description>Carbon dioxide arterial partial pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of pH</measure>
    <time_frame>The blood gas analysis will be performed at minute 10, 20, 50, 90 and 100. The values will then all be compared each other.</time_frame>
    <description>Arterial pH</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of respiratory rate</measure>
    <time_frame>The parameter will be collected at minute 10, 20, 30, 40, 50, 60, 70, 80, 90 and 100 (i.e. at the end of every step of oxygen therapy). The values obtained will then all be compared each other.</time_frame>
    <description>Respiratory rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of patient's comfort: modified Borg dyspnea scale</measure>
    <time_frame>The parameter will be collected at minute 10, 20, 30, 40, 50, 60, 70, 80, 90 and 100 (i.e. at the end of every step of oxygen therapy). The values obtained will then all be compared each other.</time_frame>
    <description>Comfort related to the oxygen therapy will be evaluated with the modified Borg dyspnea scale (0: nothing at all, 0.5: very, very slight, 1: very slight, 2: slight, 3: moderate, 4: somewhat severe, 5: severe, 6, 7: very severe, 8, 9: very, very severe - almost maximal, 10: maximal)</description>
  </secondary_outcome>
  <number_of_arms>10</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Bariatric Surgery Candidate</condition>
  <condition>Atelectasis, Postoperative Pulmonary</condition>
  <arm_group>
    <arm_group_label>Baseline conventional facemask</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The patients will receive oxygen therapy through conventional facemask for 10 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HFNC 40 L/min up</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients will receive oxygen/air mixture through high flow nasal cannula at incremental, then decremental flows, starting at 40 L/min for 10 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HFNC 60 L/min up</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High flow nasal cannula at 60 L/min for 10 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HFNC 80 L/min up</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High flow nasal cannula at 80 L/min for 10 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HFNC 100 L/min</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High flow nasal cannula at 100 L/min for 10 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HFNC 80 L/min down</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High flow nasal cannula at 80 L/min for 10 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HFNC 60 L/min down</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High flow nasal cannula at 60 L/min for 10 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HFNC 40 L/min down</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High flow nasal cannula at 40 L/min for 10 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Washout conventional facemask</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Again, the patients will receive oxygen therapy through conventional facemask for 10 minutes, to reduce the influence of HFNC on CPAP therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CPAP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients will receive CPAP at 10 cmH2O for 10 minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>High flow nasal cannula</intervention_name>
    <description>High flow of warm and humidified oxygen/air mixture delivered through nasal cannula</description>
    <arm_group_label>HFNC 100 L/min</arm_group_label>
    <arm_group_label>HFNC 40 L/min down</arm_group_label>
    <arm_group_label>HFNC 40 L/min up</arm_group_label>
    <arm_group_label>HFNC 60 L/min down</arm_group_label>
    <arm_group_label>HFNC 60 L/min up</arm_group_label>
    <arm_group_label>HFNC 80 L/min down</arm_group_label>
    <arm_group_label>HFNC 80 L/min up</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Continuous positive airway pressure</intervention_name>
    <description>Positive airway pressure applied through a sealed face mask</description>
    <arm_group_label>CPAP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Facemask</intervention_name>
    <description>Oxygen therapy through a conventional facemask</description>
    <arm_group_label>Baseline conventional facemask</arm_group_label>
    <arm_group_label>Washout conventional facemask</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient's consent to the trial

          -  Candidate to laparoscopic bariatric surgery (sleeve gastrectomy or Roux-en-Y gastric
             bypass)

          -  BMI 35-50 kg/m2

          -  ASA class 1-3

        Exclusion Criteria:

          -  Obesity hypoventilation syndrome

          -  Contraindication to EIT (e.g. implantable cardioverter-defibrillator)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lucia Comuzzi</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Sanitaria Universitaria Integrata di Trieste</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lucia Comuzzi</last_name>
    <phone>00393297835749</phone>
    <email>lucia.comz@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Azienda Sanitaria Universitaria Integrata di Trieste</name>
      <address>
        <city>Trieste</city>
        <zip>34100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lucia Comuzzi</last_name>
      <phone>00393297835749</phone>
      <email>lucia.comz@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Enrico Lena</last_name>
      <phone>00393488427261</phone>
      <email>enrico.aj.lena@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>May 3, 2019</study_first_submitted>
  <study_first_submitted_qc>June 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 5, 2019</study_first_posted>
  <last_update_submitted>June 4, 2019</last_update_submitted>
  <last_update_submitted_qc>June 4, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Trieste</investigator_affiliation>
    <investigator_full_name>Lucia Comuzzi</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>High flow nasal cannula</keyword>
  <keyword>Bariatric surgery</keyword>
  <keyword>Postoperative atelectasis</keyword>
  <keyword>Electrical impedance tomography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Atelectasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

